CAD 0.12
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.04 CAD | 18.98% |
2022 | -0.05 CAD | -30.28% |
2021 | -0.04 CAD | -57.89% |
2020 | -0.02 CAD | 45.06% |
2019 | -0.04 CAD | 48.89% |
2018 | -0.08 CAD | -3.44% |
2017 | -0.08 CAD | 62.62% |
2016 | -0.21 CAD | -1220.75% |
2015 | -0.02 CAD | 38.37% |
2014 | -0.03 CAD | -193.18% |
2013 | -0.01 CAD | 70.67% |
2012 | -0.03 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 Q3 | -0.01 CAD | 27.35% |
2023 Q1 | -0.01 CAD | 21.67% |
2023 Q4 | -0.01 CAD | 5.88% |
2023 Q2 | -0.01 CAD | -24.47% |
2022 Q3 | -0.01 CAD | -10.19% |
2022 Q4 | -0.01 CAD | -0.84% |
2022 FY | - CAD | -30.28% |
2022 Q1 | -0.01 CAD | 5.45% |
2022 Q2 | -0.01 CAD | -3.85% |
2021 Q1 | -0.01 CAD | -33.33% |
2021 FY | - CAD | -57.89% |
2021 Q4 | -0.01 CAD | -26.44% |
2021 Q3 | -0.01 CAD | -10.13% |
2021 Q2 | -0.01 CAD | 5.95% |
2020 Q4 | -0.01 CAD | -1.61% |
2020 FY | - CAD | 45.06% |
2020 Q3 | -0.01 CAD | 4.62% |
2020 Q2 | -0.01 CAD | -96.97% |
2020 Q1 | -0.00 CAD | 0.0% |
2019 Q1 | -0.01 CAD | 0.0% |
2019 FY | - CAD | 48.89% |
2019 Q4 | - CAD | 100.0% |
2019 Q3 | -0.01 CAD | 66.38% |
2019 Q2 | -0.02 CAD | -123.08% |
2018 Q2 | -0.00 CAD | 70.79% |
2018 Q1 | -0.01 CAD | 0.0% |
2018 FY | - CAD | -3.44% |
2018 Q4 | - CAD | 100.0% |
2018 Q3 | -0.01 CAD | -230.77% |
2017 Q4 | - CAD | 100.0% |
2017 Q1 | -0.02 CAD | 0.0% |
2017 FY | - CAD | 62.62% |
2017 Q2 | -0.03 CAD | -34.5% |
2017 Q3 | -0.01 CAD | 46.1% |
2016 Q4 | - CAD | 100.0% |
2016 Q3 | -0.04 CAD | -21.6% |
2016 Q2 | -0.03 CAD | 69.27% |
2016 Q1 | -0.11 CAD | -3337.5% |
2016 FY | - CAD | -1220.75% |
2015 Q2 | - CAD | -100.0% |
2015 Q1 | 0.00 CAD | 147.06% |
2015 FY | - CAD | 38.37% |
2015 Q4 | -0.00 CAD | 62.35% |
2015 Q3 | -0.01 CAD | 0.0% |
2014 Q3 | -0.00 CAD | 0.0% |
2014 Q2 | - CAD | 100.0% |
2014 FY | - CAD | -193.18% |
2014 Q1 | -0.00 CAD | 58.73% |
2014 Q4 | -0.00 CAD | -30.77% |
2013 Q3 | -0.01 CAD | 0.0% |
2013 Q1 | -0.00 CAD | 79.17% |
2013 FY | - CAD | 70.67% |
2013 Q4 | -0.01 CAD | 51.54% |
2013 Q2 | - CAD | 100.0% |
2012 Q4 | -0.00 CAD | -84.62% |
2012 Q3 | -0.00 CAD | 0.0% |
2012 Q2 | - CAD | 100.0% |
2012 FY | - CAD | 0.0% |
2012 Q1 | -0.00 CAD | 48.15% |
2011 Q3 | -0.03 CAD | 0.0% |
2011 Q4 | -0.00 CAD | 90.85% |
Name | Eps | Eps Difference |
---|---|---|
Avricore Health Inc. | -0.01 CAD | -442.857% |